Abstract
Patient similarity offers an exciting potential to improve our understanding of treatment patterns. Medication history is a valuable source of information given the clinical considerations taken during the physician’s prescription process. However, available similarity methods do not consider timeliness of event occurrence in the longitudinal care of patients.
In this observational cohort study, we propose an event alignment algorithm, Medal, which uses a dynamic programming approach for pairwise alignment of medication histories. To test our algorithm, we obtained the medication usage from a cohort of patients with pediatric acute-onset neuropsychiatric syndrome (PANS). After calculating a distance metric with Medal, we compute a hierarchical clustering and explore the most appropriate number of clusters.
We identified four clusters in PANS with distinct medication usage histories, driven primarily by penicillin. We foresee that our algorithm could be used to identify clusters in other syndromes treated with multiple medication regimens.
Competing Interest Statement
ALP declares that the research presented in this study was done while he was employed by Stanford University, but at the time of submission he is now employed by Genentech, Inc., a member of the Roche group. The rest of the authors declare no competing interests.
Funding Statement
Research reported in this publication was partially supported via institutional funds from Stanford University. CDB is a Chan Zuckerberg Biohub investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Data Availability
This study was approved by Stanford University’s Human Subjects Institutional Review Board (IRB), protocol number 26922. Parents provided consent, and competent patients provided assent. Authors CMCL, AC, and JF served as honest brokers securing identifiable information. The remaining authors only had access to de-identified information. Non-human subject determination was provided by the same IRB under protocol number 46979.